title: [Anti-typhoid vaccines].
abstract: There are three commercially available vaccines against typhoid fever: parenteral inactivated whole cell vaccine, oral live attenuated (strain ty21a), parenteral polysaccharide vaccine (capsular antigen-Vi). Their protective efficacy is 50 to 88% (inactivated vaccine), 50 to 96% (live attenuated vaccine) and 75 to 80% (polysaccharide vaccine). The frequency of notable adverse reactions with the inactivated vaccine justifies the use of the new vaccines.
authors.affiliation: Laboratoire de bactériologie-virologie, CHU Grenoble.
authors.forename: P
authors.initials: P
authors.lastname: Morand
authors.forename: J P
authors.initials: JP
authors.lastname: Stahl
mesh_terms: D000075202:Contraindications; D006801:Humans; D014435:Typhoid Fever / Q000517:prevention & control*; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects / Q000145:classification*
chemical_list: D014436:Typhoid-Paratyphoid Vaccines
vernacular_title: Vaccins antityphiques.